These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5314881)

  • 21. Clinical and laboratory experience with a modified low dosage sequential oral contraceptive.
    Wamsteker EF
    Int J Fertil; 1968; 13(4):436-43. PubMed ID: 5700403
    [No Abstract]   [Full Text] [Related]  

  • 22. The menstrual cycle after withdrawal of oral contraceptives with particular reference to return of ovulation.
    Jordan K
    Mater Med Pol; 1975; 7(2):126-32. PubMed ID: 1142823
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biological tests and iatrogenic anovulation].
    Ramírez Sánchez J; Rojas Rodríguez L; Lozano Carrillo A; Náñez Burbano H
    Rev Colomb Obstet Ginecol; 1969; 20(4):237-46. PubMed ID: 5356116
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical trial of ethynodiol diacetate in a sequential oral contraceptive.
    McBride W
    Med J Aust; 1968 Mar; 1(12):509-10. PubMed ID: 5647372
    [No Abstract]   [Full Text] [Related]  

  • 25. Preliminary clinical study of Wy 3707 with ethinyl estradiol as an oral contraceptive.
    O'Roark HC; Lock FR; Smith Foushee JH; Burt RL
    Int J Fertil; 1966; 11(4):405-11. PubMed ID: 5970363
    [No Abstract]   [Full Text] [Related]  

  • 26. Thromboembolic disease in women on sequential contraceptives with unopposed ethinyl estradiol.
    Wait RB; Sturtevant FM; Shook JG
    J Reprod Med; 1972 Aug; 9(2):41-4. PubMed ID: 5050401
    [No Abstract]   [Full Text] [Related]  

  • 27. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
    Urdinola J
    Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ovostat 22, a new oral contraceptive].
    Himmelsbach H
    Med Welt; 1974 Jan; 25(3):106-8. PubMed ID: 4840796
    [No Abstract]   [Full Text] [Related]  

  • 29. Quinestrol: a potential contraceptive agent.
    Ansari AH
    Fertil Steril; 1969; 20(3):414-8. PubMed ID: 5769389
    [No Abstract]   [Full Text] [Related]  

  • 30. [Side effects of depot contraceptives].
    Ruíz Velasco V; Alisedo Aparicio LE
    Prensa Med Mex; 1972; 37(1):25-9. PubMed ID: 5032612
    [No Abstract]   [Full Text] [Related]  

  • 31. A serial method of ovulation control using ethinyl oestradiol to suppress ovulation.
    McBride WG
    Med J Aust; 1966 Jan; 1(5):172-4. PubMed ID: 5908316
    [No Abstract]   [Full Text] [Related]  

  • 32. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Physical fitness during menstrual cycle and under estrogen progestone combination].
    Böckler H
    Dtsch Med Wochenschr; 1970 Dec; 95(49):2482-7. PubMed ID: 5486567
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety and efficacy of an extended-regimen oral contraception utilizing low-dose ethinyl estradiol.
    Anderson FD
    Contraception; 2006 Oct; 74(4):355. PubMed ID: 16982247
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical evaluation of an oral contraceptive containing Ethinyl-Oestradiol (30 mcg) and Gestoden (75 mcg).
    Ferreri R; Abbaticchio L; Blasi N; Conte R; Ierardi GM; Santamato S; Creanza V; Monterubbianesi M
    Minerva Ginecol; 1993 Dec; 45(12):609-15. PubMed ID: 8139787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The "sequential" method with a new estrogen-progesterone combination in ovulation control].
    Bailo U; Finzi C
    Minerva Ginecol; 1968 Dec; 20(23):1885-7. PubMed ID: 5734793
    [No Abstract]   [Full Text] [Related]  

  • 37. [Caproate of 17-alpha-hydroxy-19-nor-progesterone as an injectable contraceptive agent of lasting effect].
    Rodríguez-Restrepo R
    Rev Colomb Obstet Ginecol; 1969; 20(4):247-55. PubMed ID: 5356117
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative studies on the ovulation inhibitor Tri-Ervonum following a more-than-1-year administration].
    McBride WG; MacMillan IS; Heber KR
    Fortschr Med; 1975 Sep; 93(27):1295-8. PubMed ID: 1222929
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect and tolerance of a low dose ovulation inhibitor (Orlest)].
    Koester H; Hertel H
    Munch Med Wochenschr; 1969 Oct; 111(41):2103-9. PubMed ID: 5395280
    [No Abstract]   [Full Text] [Related]  

  • 40. A low-dose combination oral contraceptive. Experience with 1,700 women treated for 22,489 cycles.
    Woutersz TB
    J Reprod Med; 1981 Dec; 26(12):615-20. PubMed ID: 7033528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.